Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Marks

Showing results (501-510 of 683) with videos related to

Pageof 69
Sort By:
British Journal of Haematology|March 23, 1999
Infections in adults undergoing unrelated donor bone marrow transplantationE C Williamson, M R Millar, C G Steward, et al.
British Journal of Haematology|July 29, 2021
Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantationMaria Gabelli, David I Marks, Kirsty Sharplin, et al.
Blood Cancer Journal|August 10, 2020
Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burdenDaniel J DeAngelo, Anjali S Advani, David I Marks, et al.
Bone Marrow Transplantation|March 2, 2011
The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation studyR E Protheroe, K E Kirkland, R M Pearce, et al.
The British Journal of Dermatology|June 14, 2005
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trialA B Gottlieb, C E M Griffiths, V C Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 1, 2019
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic LeukemiaDavid I Marks, Partow Kebriaei, Matthias Stelljes, et al.
British Journal of Haematology|September 27, 2003
The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantationJ Paul Kerr, Effie Liakopolou, Jessica Brown, et al.
Transfusion Medicine (Oxford, England)|May 18, 2012
The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasmaEdwin Massey, Kay Harding, Brennan C Kahan, et al.
British Journal of Haematology|August 29, 1998
The outcome of children requiring admission to an intensive care unit following bone marrow transplantationC Hayes, R J Lush, J M Cornish, et al.
Blood|April 27, 2011
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemiaJudith C Marsh, Vikas Gupta, Ziyi Lim, et al.
Pageof 69

Showing results (501-510 of 683) with videos related to

Sort By:
Pageof 69
British Journal of Haematology|March 23, 1999
Infections in adults undergoing unrelated donor bone marrow transplantationE C Williamson, M R Millar, C G Steward, et al.
British Journal of Haematology|July 29, 2021
Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantationMaria Gabelli, David I Marks, Kirsty Sharplin, et al.
Blood Cancer Journal|August 10, 2020
Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burdenDaniel J DeAngelo, Anjali S Advani, David I Marks, et al.
Bone Marrow Transplantation|March 2, 2011
The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation studyR E Protheroe, K E Kirkland, R M Pearce, et al.
The British Journal of Dermatology|June 14, 2005
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trialA B Gottlieb, C E M Griffiths, V C Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 1, 2019
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic LeukemiaDavid I Marks, Partow Kebriaei, Matthias Stelljes, et al.
British Journal of Haematology|September 27, 2003
The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantationJ Paul Kerr, Effie Liakopolou, Jessica Brown, et al.
Transfusion Medicine (Oxford, England)|May 18, 2012
The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasmaEdwin Massey, Kay Harding, Brennan C Kahan, et al.
British Journal of Haematology|August 29, 1998
The outcome of children requiring admission to an intensive care unit following bone marrow transplantationC Hayes, R J Lush, J M Cornish, et al.
Blood|April 27, 2011
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemiaJudith C Marsh, Vikas Gupta, Ziyi Lim, et al.
Pageof 69